Speakers
Katerina Akassoglou, University of California, USA
The immunology of blood: Unlocking drivers of neurodegeneration
Katerina Akassoglou
Kari Alitalo, University of Helsinki, Finland
Targeting meningeal lymphatics in CNS disease
Kari Alitalo
Christer Betsholtz, Karolinska Institutet and Uppsala University, Sweden
Mapping the brain barriers by single-cell RNA sequencing
Christer Betsholtz
Matthew Campbell, Trinity College Dublin, Ireland
Dynamic regulation of claudin-5 at the blood-brain and blood-retina barrier
Matthew Campbell
Peter Carlsson, University of Gothenburg, Sweden
Foxf2 control of brain endothelial metabolism and consequences for neuronal health and survival
Peter Carlsson
William Elmquist, University of Minnesota, USA
Heterogeneity in Transport Mechanisms at the BBB: A critical determinant of efficacy in brain tumors
William Elmquist
Britta Engelhardt, University of Bern, Switzerland
The brain barriers maintain CNS immune privilege
Britta Engelhardt
Viviana Gradinaru, Caltech, USA
Engineered gene delivery vectors for high-precision minimally-invasive access to and across the brain vasculature across species
Viviana Gradinaru
Margareta Hammarlund-Udenaes, Uppsala University, Sweden
Targeting CNS disorders – is enough drug reaching the brain? On drug delivery across the blood-brain barrier.
Margareta Hammarlund-Udenaes
Annika Keller, University Hospital Zurich, Switzerland
Pericytes regulate vascular immune homeostasis in the CNS
Annika Keller
Maria Lehtinen, Boston Children’s Hospital, USA
New roles for the blood-CSF barrier in health and disease
Maria Lehtinen
Stefan Liebner, Goethe University Frankfurt, Germany
Regulation of endothelial permeability in circumventricular organs (CVOs) – sites of neurovascular coupling
Stefan Liebner
Maiken Nedergaard, Nedergaard Lab, USA and University of Copenhagen, Denmark
The Glymphatic System
Maiken Nedergaard
Prakash Ambady and Edward Neuwelt, Oregon Health & Science University, USA
Looking back at the past 50 years of intra-arterial delivery and blood-brain barrier disruption
Prakash Ambady and Edward Neuwelt
Timothy Phoenix, University of Cincinnati, USA
Drivers of vascular heterogeneity in brain tumors
Timothy Phoenix
Jann Sarkaria, Mayo Clinic, USA
Distribution of the novel DNA-PK inhibitor nedisertib into brain and brain tumor and the impact on radiation sensitivity
Jann Sarkaria
Stina Syvänen, Uppsala University, Sweden
Bispecific brain penetrating antibodies for PET imaging and therapy
Stina Syvänen
Rudolph Tanzi, Massachusetts General Hospital East, USA
The Role of Innate Immunity in Alzheimer’s Disease Pathogenesis
Rudolph Tanzi
Li-Huei Tsai, Massachusetts Institute of Technology, USA
Using human stem cells and postmortem brains to study vascular dysfunction in Alzheimer’s disease
Li-Huei Tsai
Benoit Vanhollebeke, Université Libre de Bruxelles, Belgium
Single-cell control mechanism of brain angiogenesis and blood-brain barrier formation in vertebrates
Benoit Vanhollebeke
Berislav V. Zlokovic, University of Southern California, USA
Blood-brain barrier Link to Neurodegeneration: Implications for cognitive impairment, dementia and Alzheimer’s disease
Berislav V. Zlokovic
Joy Zuchero, Denali Therapeutic Inc. USA
Using the Transport Vehicle to Deliver CNS Therapeutics Across the Blood-Brain Barrier
Joy Zuchero
Professional Conference Organiser
For general information, please contact: